✦ LIBER ✦

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

✍ Scribed by Bojana Milojkovic Kerklaan, Veronique Diéras…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Phase I study of lonafarnib

✍ Bojana Milojkovic Kerklaan, Veronique Diéras… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 95 KB

0180 Weekly paclitaxel plus carboplatin

✍ X. Chen; C. Chen; J. Wu; J. Wu; J. Lu; Z. Shao; Z. Shen; K. Shen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase I Study of Nonpegylated Liposomal

✍ Maria Theodoulou; Gerald Batist; Susana Campos; Eric Winer; Lauri Welles; Cliffo 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 127 KB

A phase 2 study of everolimus combined w

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB

5076 POSTER Phase II Study of Vinorelbin

✍ Kwon, H.; Oh, S.Y.; Kim, S.H.; Lee, S.; Lee, J.H.; Kim, H.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A Phase I/II Trial of Trastuzumab and Ge

✍ Stacy L. Moulder; Carlos L. Arteaga 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB